rs2569190
This is a regulatory region variant variant in the CD14 gene.
▶Research that mentions this SNP (6)
▶Single nucleotide polymorphisms of IL-13 and CD14 genes in allergic rhinitis: a meta-analysisMeta-analysisN=15,428Min-Li Chen et al.(2018)· European Archives of Oto-Rhino-Laryngology
A meta-analysis of 21 case-control studies examining IL-13 and CD14 gene polymorphisms in allergic rhinitis (AR). The A allele of IL-13 SNP rs20541 was significantly associated with increased AR risk in Asians (OR 1.21, 95% CI 1.11-1.32, P<0.001) but not in Caucasians. No significant associations were found for IL-13 rs1800925 or CD14 rs2569190 with AR risk in either ethnic group.
▶Toll‐like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infectionAssociationN=180Eva Askar et al.(2010)· Journal of Medical Virology
This study examined 136 chronic hepatitis C patients for the TLR7 rs179008/Gln11Leu SNP and found the variant T allele associated with portal lymphoid aggregates (P=0.013 in males, P=0.032) and significantly lower hepatic IL-29/IFNλ1 expression (P=0.015) and IL-28 receptor expression. The T allele showed a trend toward reduced interferon-alpha treatment response (30% vs 63% response, P=0.069).
▶Association of CD14 variant with prostate cancer in African American menAssociationN=442Tshela E. Mason et al.(2010)· The Prostate
This case-control association study examined the CD14 promoter -260 C>T variant (rs2569190) in 254 African American prostate cancer cases and 188 controls. The C genotypes showed marginal association with prostate cancer overall (P=0.07), but significant association in men ≥55 years (OR: 2.18, 95% CI: 1.07-4.44, P<0.05) and specifically in African Americans (OR: 2.40, 95% CI: 1.20-4.70, P<0.05), suggesting inflammatory pathway genetic variation contributes to prostate cancer susceptibility.
▶Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposisAssociationN=332Joel M. Bernstein et al.(2009)· The Laryngoscope
Case-control study of 179 patients with chronic hyperplastic sinusitis with nasal polyposis (CHSwNP) and 153 controls examining 14 cytokine gene polymorphisms. The TNFα -308 SNP (rs1800629) was significantly associated with nasal polyposis susceptibility, with the A allele present in 18.6% of cases versus 11.5% of controls (odds ratio 1.86, 95% CI 1.14-3.09). All other cytokine polymorphisms tested were not statistically significant.
▶CD14 C260T promoter polymorphism and the risk of cerebrovascular diseases: a meta-analysisMeta-analysisN=3,088Banerjee I. et al.(2009)· Journal of Applied Genetics
Meta-analysis of 7 case-control studies (1488 CVD patients, 1600 controls) examining the CD14 C260T polymorphism (rs2569190) as a risk factor for cerebrovascular disease. The T allele showed no significant association with CVD risk under either fixed or random effects models (OR=0.99, 95% CI 0.89-1.09, p=0.84), and similar null findings were observed for genotype comparisons.
▶Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activityFunctionalN=42Jasmin Mertens et al.(2009)· Journal of Molecular Medicine
This functional study investigates the molecular mechanisms of the CD14 rs2569190 polymorphism in peripheral blood mononuclear cells using chromatin immunoprecipitation and allele-specific transcript quantification. The T allele of rs2569190 showed approximately twice the recruitment of serine-5-phosphorylated RNA polymerase II compared to the C allele, suggesting enhanced transcription initiation; however, transcript abundance was similar between alleles. The findings indicate that rs2569190 affects transcription initiation but not mRNA expression levels in PBMC, and suggest that endotoxin sensitivity associated with this polymorphism may depend on tissue-specific effects in hepatic or other cell types rather than myeloid CD14 expression.
About CD14
The protein encoded by this gene is a surface antigen that is preferentially expressed on monocytes/macrophages. It cooperates with other proteins to mediate the innate immune response to bacterial lipopolysaccharide, and to viruses. This gene has been identified as a target candidate in the treatment of SARS-CoV-2-infected patients to potentially lessen or inhibit a severe inflammatory response. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Aug 2020]
View all CD14 variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…